Company Encyclopedia
View More
name
Arcadia Biosciences
RKDA.US
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
63.54 B
RKDA.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Agricultural Products and ServicesIndustry
Industry Ranking11/23
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-64.08%E
    • Profit Margin-97.95%E
    • Gross Margin32.10%C
  • Growth ScoreC
    • Revenue YoY12.31%B
    • Net Profit YoY13.04%C
    • Total Assets YoY-43.68%E
    • Net Assets YoY-46.37%E
  • Cash ScoreC
    • Cash Flow Margin-102.09%D
    • OCF YoY12.31%B
  • Operating ScoreC
    • Turnover0.43C
  • Debt ScoreB
    • Gearing Ratio36.59%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Arcadia Biosciences Inc. Announces Date for Upcoming Annual Meeting of Stockholders

    Arcadia Biosciences Inc. will hold its Annual Meeting of Stockholders on December 19, 2025, allowing shareholders to vote on various matters. This announcement was originally published via EDGAR by Arcadia Biosciences Inc. on November 19, 2025.

    Reuters·
    US
    RKDA
    -0.27%
    Reuters·
    US
    RKDA
    -0.27%

    Arcadia Biosciences Inc expected to post a loss of 66 cents a share - Earnings Preview

    Arcadia Biosciences Inc is expected to report a quarterly revenue increase of 15.1% to $1.4 million on November 10, 2025, despite an anticipated loss of 66 cents per share. The company's earnings estimates have decreased by 14.9% over the past three months. Currently, the only analyst rating is "buy," with a median 12-month price target of $12.00, representing a potential upside of 69.3% from its last closing price of $3.69.

    Reuters·
    US
    RKDA
    -0.27%
    Reuters·
    US
    RKDA
    -0.27%

    Arcadia Biosciences ( RKDA ) Announces Third Quarter 2025 Financial Results and Business Highlights

    -- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS, Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Arcadia Biosciences, Inc.® ( Nasdaq: RKDA ) , a producer and ...

    GlobeNewswire·
    US
    RKDA
    -0.27%
    GlobeNewswire·
    US
    RKDA
    -0.27%

    Arcadia Biosciences | 10-Q: FY2025 Q3 Revenue Misses Estimate at USD 1.302 M

    LB filings·
    US
    RKDA
    -0.27%
    LB filings·
    US
    RKDA
    -0.27%

    Arcadia Biosciences | 8-K: FY2025 Q3 Revenue Misses Estimate at USD 1.302 M

    LB filings·
    US
    RKDA
    -0.27%
    LB filings·
    US
    RKDA
    -0.27%
    © 2025 Longbridge｜Disclaimer